Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website http://www.gastrores.org

Original Article

Volume 2, Number 6, December 2009, pages 344-349

Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease

Tables

Table 1. Gender Distribution of HBV-related Liver Disease
 
Liver DiseaseMaleFemaleTotal (%)
HCC: Hepatocellular carcinoma
Asymptomatic36642 (29.6)
Chronic Hepatitis9312 (8.4)
Cirrhosis35439 (27.5)
HCC361349 (34.5)

 

Table 2. Platelet Count in HBV-related Liver Disease
 
Liver DiseaseMean Platelet Count (×109/L)
HCC: Hepatocellular carcinoma
HBV-related liver disease patients (n = 142)208.866 ± 128.504
Asymptomatic (n = 42)197.0 ± 66.464
Chronic Hepatitis (n = 12)200.333 ± 50.878
Cirrhosis (n = 39)105.692 ± 23.933
HCC (n = 49)303.245 ± 160.639

 

Table 3. Comparing Platelet Count At Different Stages of HBV-related Liver Disease
 
Liver Diseaset valuedfp value
HCC: Hepatocellular carcinoma. * statistically significant
Control versus HBV-related liver disease0.73131870.4655
Control versus Asymptomatic0.1746870.8618
Asymptomatic versus Chronic Hepatitis0.1604520.8732
Asymptomatic versus Cirrhosis8.10279< 0.0001*
Cirrhosis versus HCC7.60486< 0.0001*
Asymptomatic versus HCC4.0890.0001*
Control versus HCC4.33394< 0.0001*